WayneMacfaddenMD

PubMed

• Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
  Russell Rosenberg, Rogelio Braceras, Wayne Macfadden, Shawn Candler, Jed Black, Chad Ruoff> ;Neurology and Therapy. 2023 Dec 1
• Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.
  Franck Skobieranda, Shawn Candler, Wayne Macfadden> ;Sleep. 2022 Jun 13
• 8 citations
  Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration - results from the rand...
  Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr Kolar> ;BMC Ophthalmology. 2020 Jan 9
• 35 citations
  Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
  Joseph R. Calabrese, Maurizio Fava, George Garibaldi, Heinz Grunze, Andrew D. Krystal, Thomas Laughren, Wayne Macfadden, Robert S. Marin, Andrew A. Nierenberg, Maurici...> ;Journal of Affective Disorders. 2014 Oct 15
• 19 citations
  Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms
  Wayne Macfadden, Caleb M. Adler, Ibrahim Turkoz, John Thomas Haskins, Norris Turner, Larry Alphs> ;BMC Psychiatry. 2011 Oct 28
• 25 citations
  Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clin...
  Concetta Crivera, Cherilyn DeSouza, Chris M. Kozma, Riad Dirani, Lian Mao, Wayne Macfadden> ;BMC Psychiatry. 2011 Oct 14
• 24 citations
  Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
  Wayne Macfadden, Cherilyn DeSouza, Concetta Crivera, Chris M. Kozma, Riad Dirani, Lian Mao, Stephen C. Rodriguez> ;BMC Psychiatry. 2011 Oct 14
• Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder
  Norris Turner, Wayne Macfadden, Ravi Anand, Sumant Khanna, Mark Hyman Rapaport, J. Thomas Haskins, Ibrahim Turkoz, Larry Alphs> ;Innovations in Clinical Neuroscience. 2011 Oct 1
• 10 citations
  Health Care Resource Utilization and Costs in a Commercially Insured Population of Patients With Bipolar Disorder Type I and Frequent Psychiatric Interventions
  Erin Bagalman, Erik Muser, Jiyoon C. Choi, Emily Durden, Wayne Macfadden, J. Thomas Haskins, Riad Dirani> ;Clinical Therapeutics. 2011 Oct 1
• 37 citations
  Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.
  Tim Lambert, José M. Olivares, Joseph Peuskens, Cherilyn DeSouza, Chris M. Kozma, Patrick Otten, Concetta Crivera, An Jacobs, Wayne Macfadden, Lian Mao, Stephen C. Rod...> ;Annals of General Psychiatry. 2011 Apr 4
• 9 citations
  Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a Medicaid population.
  Emily Durden, Erin Bagalman, Erik Muser, Jiyoon C. Choi, Concetta Crivera, Riad Dirani, Wayne Macfadden, J. Thomas Haskins> ;Journal of Medical Economics. 2010 Dec 7
• 48 citations
  A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia.
  Wayne Macfadden, Y.W. Ma, Thomas Haskins J, Cynthia A. Bossie, Alphs L> ;Psychiatry. 2010 Nov 1
• 5 citations
  Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions
  J. Thomas Haskins, Wayne Macfadden, Norris Turner, Concetta Crivera, Riad Dirani, Larry Alphs, Kenneth Gersing, Bruce M. Burchett> ;Journal of Medical Economics. 2010 Sep 14
• 12 citations
  Assessment of clinician awareness of nonadherence using a new structured rating scale.
  Carol D. Clayton, Jeffrey Veach, Wayne Macfadden, John Thomas Haskins, John P. Docherty, Jean-pierre Lindenmayer> ;Journal of Psychiatric Practice. 2010 May 1
• 18 citations
  Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
  Wayne Macfadden, Cynthia A. Bossie, Ibrahim Turkoz, John Thomas Haskins> ;International Clinical Psychopharmacology. 2010 Mar 1
• 87 citations
  A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who r...
  Wayne Macfadden, Larry Alphs, J Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia A. Bossie, Mary J. Kujawa, Ramy Mahmoud> ;Bipolar Disorders. 2009 Dec 1
• 65 citations
  A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
  Kyle M. Kampman, Helen M. Pettinati, Kevin G. Lynch, Tom Whittingham, Wayne Macfadden, Charles A. Dackis, Carlos F. Tirado, David W. Oslin, Thorne Sparkman, Charles P....> ;Journal of Clinical Psychopharmacology. 2007 Aug 1
• 75 citations
  Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled ...
  Eduard Vieta, Joseph R. Calabrese, Jose Manuel Goikolea, Shane Raines, Wayne Macfadden> ;Bipolar Disorders. 2007 Jun 1
• 27 citations
  Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-contr...
  John Cookson, Paul E. Keck, Terence A. Ketter, Wayne Macfadden> ;International Clinical Psychopharmacology. 2007 Mar 1
• 380 citations
  Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
  Michael E. Thase, Wayne Macfadden, Richard H. Weisler, William Chang, Björn Paulsson, Arifulla Khan, Joseph R. Calabrese> ;Journal of Clinical Psychopharmacology. 2006 Dec 1
• 75 citations
  Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
  Robert M. A. Hirschfeld, Richard H. Weisler, Shane Raines, Wayne Macfadden> ;The Journal of Clinical Psychiatry. 2006 Mar 15
• 560 citations
  A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
  Joseph R. Calabrese, Paul E. Keck, Wayne Macfadden, Margaret Minkwitz, Terence A. Ketter, Richard H. Weisler, Andrew J. Cutler, Robin Mccoy, Ellis Wilson, Jamie Mullen> ;The American Journal of Psychiatry. 2005 Jul 1
• 2 citations
  Reply to article by Margolese and associates on tolerance and rebound during maintenance with quetiapine.
  Jeffrey Goldstein, Wayne Macfadden> ;Journal of Clinical Psychopharmacology. 2004 Feb 1
• Diabetes and atypical neuroleptics.
  Wayne K. Geller, Wayne Macfadden> ;The American Journal of Psychiatry. 2003 Feb 1
• 80 citations
  Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts
  Paul J. Fudala, Elmer Yu, Wayne Macfadden, Chris Boardman, C. Nora Chiang> ;Drug and Alcohol Dependence. 1998 Mar 1
• Join now to see all